Form 4: ProMIS Neurosciences Director Michael S. Gordon Restructures Share Holdings

ProMIS Neurosciences Inc. Director and 10% Owner Michael S. Gordon reported a transfer of 93,223 common shares into a limited liability company in exchange for membership interests.

Summary

• Michael S. Gordon, a Director and 10% Owner of ProMIS Neurosciences Inc. (PMN), reported a change in beneficial ownership.
• On June 30, 2025, Gordon contributed 93,223 common shares of ProMIS Neurosciences to Skye Peak Partners LLC (SPP) in exchange for membership interests in SPP.
• Following this transaction, Gordon directly owns 0 common shares.
• Gordon indirectly beneficially owns 2,075,629 common shares through Title 19 Promis, a series of a Delaware limited liability company where he is the sole manager.
• Gordon also indirectly beneficially owns 48,333 common shares through Title 19 Acies, a series of a Delaware limited liability company, where SPP is the sole member and the ownership interests inure to the benefit of a trust whose trustee is Gordon's spouse.

Sentiment

Score: 5

Explanation: The document is a factual report of an insider's share transfer and does not contain information that would inherently indicate a positive or negative outlook for the company.

Future Outlook

No forward-looking statements or guidance provided.

Industry Context

This Form 4 reports a specific insider transaction and does not provide information relevant to broader industry trends or competitors.

Related Party Transactions

• The transaction involves the transfer of shares by a director and 10% owner to entities (Skye Peak Partners LLC, Title 19 Promis, Title 19 Acies) over which he or his spouse maintains control or beneficial interest, representing a restructuring of personal holdings.

Stakeholder Impact

• The direct impact on shareholders, employees, customers, suppliers, and creditors is minimal, as this transaction primarily represents an internal restructuring of an insider's personal shareholdings rather than a change in the company's operations or financial position.

Key Dates

Keywords

ProMIS Neurosciences Inc., PMN, Michael S. Gordon, SEC Form 4, Beneficial Ownership, Insider Transaction, Stock Transfer, Equity Restructuring, Director Holdings, 10% Owner